Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Cystic Fibrosis (CF) Therapeutics Global Market Report 2025
Request Sample Buy Now
Global Cystic Fibrosis (CF) Therapeutics Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Cystic Fibrosis (CF) Therapeutics Global Market Report 2025

By Drug Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators), By Route Of Administration (Oral, Inhaled), By Treatment Method (Medication, Devices) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cystic Fibrosis (CF) Therapeutics Market Overview

• Cystic Fibrosis (CF) Therapeutics market size has reached to $7.63 billion in 2024

• Expected to grow to $10.92 billion in 2029 at a compound annual growth rate (CAGR) of 7%

• Growth Driver: Growing Patient Numbers Drive Momentum in Cystic Fibrosis Therapeutics Market

• Market Trend: Fibrosis Innovation Hub Network To Accelerate CF Treatment Development

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cystic Fibrosis (CF) Therapeutics Market?

Cystic fibrosis (CF) therapeutics refers to medications that thin and facilitate coughing up lung mucus. It is an inherited disorder that causes severe damage to the lungs, digestive system, and other organs in the body.

The main drug classes for cystic fibrosis (CF) therapeutics are pancreatic enzyme supplements, mucolytics, bronchodilators and CFTR modulators. Pancreatic enzyme supplements refer to supplements produced by the pancreas and containing pancreatin or pancrelipase, which is a combination of lipase, amylase, and protease. There are two routes of administration such as oral and inhaled. It includes methods of cystic fibrosis treatment with medication and devices.

Cystic Fibrosis (CF) Therapeutics Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

What Is The Cystic Fibrosis (CF) Therapeutics Market Size 2025 And Growth Rate?

The cystic fibrosis (CF) therapeutics market size has grown rapidly in recent years. It will grow from $7.63 billion in 2024 to $8.34 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to advancements in targeted therapies, growing understanding of CF genetics, patient advocacy and awareness, government support for research, orphan drug designations, incentives for rare disease research.

What Is The Cystic Fibrosis (CF) Therapeutics Market Growth Forecast?

The cystic fibrosis (CF) therapeutics market size is expected to see strong growth in the next few years. It will grow to $10.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to rise in C patient population, regulatory approvals for novel therapies, focus on personalized medicine, increasing investment in biomarker research, expanded newborn screening programs, healthcare policy support. Major trends in the forecast period include expansion of CFTR modulators, gene editing technologies, early intervention strategies, improved diagnostic techniques, telehealth and remote monitoring, healthcare digitalization, chronic disease management.

The forecast of 7.0% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. pulmonary specialty clinics by inflating prices of cystic fibrosis transmembrane conductance regulator modulator therapies manufactured in Ireland and Switzerland, resulting in reduced cystic fibrosis management options and higher rare disease treatment costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Cystic Fibrosis (CF) Therapeutics Market Segmented?

1) By Drug Class: Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators

2) By Route Of Administration: Oral, Inhaled

3) By Treatment Method: Medication, Devices

Subsegments:

1) By Pancreatic Enzyme Supplements: Lipase, Amylase, Protease

2) By Mucolytics: Dornase Alfa (Pulmozyme), Hypertonic Saline

3) By Bronchodilators: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Anticholinergics

4) By CFTR Modulators: Ivacaftor, Lumacaftor Or Ivacaftor (Orkambi), Tezacaftor Or Ivacaftor (Symdeko), Elexacaftor Or Tezacaftor Or Ivacaftor

What Is Driving The Cystic Fibrosis (CF) Therapeutics Market? Growing Patient Numbers Drive Momentum in Cystic Fibrosis Therapeutics Market

An increase in the number of patients suffering from cystic fibrosis is expected to propel the growth of the cystic fibrosis (CF) therapeutics market going forward. Cystic fibrosis (CF) is an inherited condition that severely harms the body's lungs, digestive system, and other organs. Cystic fibrosis therapeutics are used to treat cystic fibrosis disorder by making the mucus in the lungs thinner and easier to cough up. Thus, an increase in the number of patients suffering from cystic fibrosis is expected to boost the cystic fibrosis (CF) therapeutics market. For instance, in July 2022, according to a report shared by The Cystic Fibrosis (CF) Foundation, a US-based non-profit organization, there has been an upsurge in the number of people with cystic fibrosis, in 2022 cystic fibrosis affects almost 40,000 children and adults in the United States, and over 105,000 people worldwide have been diagnosed. Therefore, an increase in the number of patients suffering from cystic fibrosis is driving the growth of the cystic fibrosis (CF) therapeutics industry.

What Is Driving The Cystic Fibrosis (CF) Therapeutics Market? Personalized Medicine And Targeted Therapies Reshape Cystic Fibrosis (CF) Treatment Landscape

An increasing focus on personalized medicine and targeted therapies is expected to propel the growth of the cystic fibrosis (CF) therapeutics market going forward. Personalized medicine, or personalized care, refers to the method by which medical professionals study patients' unique genes, proteins, and other bodily components to provide and organize customized care through the use of precision medicine. Personalized medicine helps in the understanding of the genetic mutations that cause cystic fibrosis in detail to offer customized treatment plans based on each patient's unique genetic profile as the genetic basis of cystic fibrosis (CF) becomes clear. For instance, according to The Scope and Significance of Progress in 2022 report by the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the US Food and Drug Administration (FDA) approved 12 personalized medicines, which accounted for approximately 34% of all newly approved therapeutic molecular entities. Therefore, an increasing focus on personalized medicine and targeted therapies is driving the growth of the cystic fibrosis (CF) therapeutics industry.

Who Are The Major Players In The Global Cystic Fibrosis (CF) Therapeutics Market?

Major companies operating in the cystic fibrosis (CF) therapeutics market include Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici SpA, PTC Therapeutics LIMITED, Genentech Inc., Alaxia, AstraZeneca, Beyond Air Inc., Pfizer Inc., Alcresta Therapeutics Inc., Laurent Pharmaceuticals, Nestlé HealthScience, Pharmaxis, Bayer AG, AbbVie Inc., Novartis AG, Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals Inc, ProQR Therapeutics N.V., Enterprise Therapeutics Ltd. , Corbus Pharmaceuticals Holdings Inc, Eloxx Pharmaceuticals , Translate Bio Inc, Zambon S.p.A

What Are The Key Trends Of The Global Cystic Fibrosis (CF) Therapeutics Market? Fibrosis Innovation Hub Network To Accelerate CF Treatment Development

Major companies operating in the cystic fibrosis (CF) therapeutics market are innovating treatment and patient care solutions, such as the cystic fibrosis innovation hub network, to accelerate research, improve treatment options, and enhance collaboration in the development of new therapies for CF patients. The cystic fibrosis innovation hub network is a collaborative platform or initiative designed to accelerate the research and development of new treatments for cystic fibrosis (CF). For instance, in October 2024, LifeArc, a UK-based charity and life sciences company that focuses on translating scientific research into viable healthcare solutions, launched the UK’s first Cystic Fibrosis Innovation Hub Network. Cystic Fibrosis Innovation Hub Network is designed to enhance research and development for cystic fibrosis (CF) treatments, fostering collaboration between healthcare providers, researchers, and patients. Launched as part of a broader initiative to accelerate innovation in cystic fibrosis therapies, the hub focuses on identifying new pathways for drug development and improving patient outcomes.

What Are The Key Trends Of The Global Cystic Fibrosis (CF) Therapeutics Market? CF Foundation's Investment Accelerates Innovation In Cystic Fibrosis (CF) Therapeutics

Major companies operating in the cystic fibrosis (CF) therapeutics market are focused on investing to expand their footprints and strengthen their position in the market. Strategic investment in medical research describes the deliberate and organized distribution of funds, labor, and knowledge into scientific research projects with the goals of expanding our knowledge of medical disorders, creating novel treatments, and enhancing healthcare procedures. In January 2023, the Cystic Fibrosis Foundation (CF Foundation), a US-based non-profit organization that supports a broad range of research initiatives to cure cystic fibrosis, announced a strategic investment of up to $15 million in ReCode Therapeutics, a US-based clinical-stage genetic medicines and biotechnology company that uses superior delivery to power the next wave of messenger ribonucleic acid (mRNA) and gene correction therapeutics. ReCode will use the funds to develop its inhaled mRNA-based therapeutic for people with cystic fibrosis (CF), including those with genotypes that do not respond to approved cystic fibrosis transmembrane conductance regulator (CFTR) modulators.

Need data on a specific region in this market?
Request Customisation

Cystic Fibrosis (CF) Therapeutics Market Merger And Acquisition: Sionna Therapeutics Acquires Rights To Develop And Commercialize Cystic Fibrosis Compounds From Abbvie

In July 2024, Sionna Therapeutics, a US-based healthcare organization acquired rights to develop and commercialize multiple cystic fibrosis (CF) compounds from AbbVie inc, for an undisclosed amount. With this acquisition, Sionna commercializes three specific compounds: ABBV-2222, ABBV-3067, and ABBV-2851 to improve efficiency for cystic fibrosis (CF) treatment. AbbVie Inc. is a US-based company that provides cystic fibrosis (CF) therapeutics.

Regional Analysis For The Global Cystic Fibrosis (CF) Therapeutics Market

North America was the largest region in the cystic fibrosis (CF) therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cystic fibrosis (CF) therapeutics market during the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cystic Fibrosis (CF) Therapeutics Market?

The cystic fibrosis (CF) therapeutics market includes revenues earned by entities by providing services that include administration of mucus thinner, airway clearance, and antibiotics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cystic Fibrosis (CF) Therapeutics Industry?

The cystic fibrosis (cf) therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cystic fibrosis (cf) therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cystic Fibrosis (CF) Therapeutics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $8.34 billion
Revenue Forecast In 2034 $10.92 billion
Growth Rate CAGR of 7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Class: Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators
2) By Route Of Administration: Oral, Inhaled
3) By Treatment Method: Medication, Devices Subsegments: 1) By Pancreatic Enzyme Supplements: Lipase, Amylase, Protease
2) By Mucolytics: Dornase Alfa (Pulmozyme), Hypertonic Saline
3) By Bronchodilators: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Anticholinergics
4) By CFTR Modulators: Ivacaftor, Lumacaftor Or Ivacaftor (Orkambi), Tezacaftor Or Ivacaftor (Symdeko), Elexacaftor Or Tezacaftor Or Ivacaftor
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici SpA, PTC Therapeutics LIMITED, Genentech Inc., Alaxia, AstraZeneca, Beyond Air Inc., Pfizer Inc., Alcresta Therapeutics Inc., Laurent Pharmaceuticals, Nestlé HealthScience, Pharmaxis, Bayer AG, AbbVie Inc., Novartis AG, Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals Inc, ProQR Therapeutics N.V., Enterprise Therapeutics Ltd. , Corbus Pharmaceuticals Holdings Inc, Eloxx Pharmaceuticals , Translate Bio Inc, Zambon S.p.A
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Cystic Fibrosis (CF) Therapeutics Market Characteristics

3. Cystic Fibrosis (CF) Therapeutics Market Trends And Strategies

4. Cystic Fibrosis (CF) Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cystic Fibrosis (CF) Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Cystic Fibrosis (CF) Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cystic Fibrosis (CF) Therapeutics Market Growth Rate Analysis

5.4. Global Cystic Fibrosis (CF) Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cystic Fibrosis (CF) Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cystic Fibrosis (CF) Therapeutics Total Addressable Market (TAM)

6. Cystic Fibrosis (CF) Therapeutics Market Segmentation

6.1. Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pancreatic Enzyme Supplements

Mucolytic

Bronchodilators

CFTR Modulators

6.2. Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Inhaled

6.3. Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medication

Devices

6.4. Global Cystic Fibrosis (CF) Therapeutics Market, Sub-Segmentation Of Pancreatic Enzyme Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lipase;

Amylase

Protease

6.5. Global Cystic Fibrosis (CF) Therapeutics Market, Sub-Segmentation Of Mucolytics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dornase Alfa (Pulmozyme)

Hypertonic Saline

6.6. Global Cystic Fibrosis (CF) Therapeutics Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Short-Acting Beta Agonists (SABAs)

Long-Acting Beta Agonists (LABAs)

Anticholinergics

6.7. Global Cystic Fibrosis (CF) Therapeutics Market, Sub-Segmentation Of CFTR Modulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ivacaftor

Lumacaftor Or Ivacaftor (Orkambi)

Tezacaftor Or Ivacaftor (Symdeko)

Elexacaftor Or Tezacaftor Or Ivacaftor

7. Cystic Fibrosis (CF) Therapeutics Market Regional And Country Analysis

7.1. Global Cystic Fibrosis (CF) Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cystic Fibrosis (CF) Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market

8.1. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cystic Fibrosis (CF) Therapeutics Market

9.1. China Cystic Fibrosis (CF) Therapeutics Market Overview

9.2. China Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cystic Fibrosis (CF) Therapeutics Market

10.1. India Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cystic Fibrosis (CF) Therapeutics Market

11.1. Japan Cystic Fibrosis (CF) Therapeutics Market Overview

11.2. Japan Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cystic Fibrosis (CF) Therapeutics Market

12.1. Australia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cystic Fibrosis (CF) Therapeutics Market

13.1. Indonesia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cystic Fibrosis (CF) Therapeutics Market

14.1. South Korea Cystic Fibrosis (CF) Therapeutics Market Overview

14.2. South Korea Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cystic Fibrosis (CF) Therapeutics Market

15.1. Western Europe Cystic Fibrosis (CF) Therapeutics Market Overview

15.2. Western Europe Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cystic Fibrosis (CF) Therapeutics Market

16.1. UK Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cystic Fibrosis (CF) Therapeutics Market

17.1. Germany Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cystic Fibrosis (CF) Therapeutics Market

18.1. France Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cystic Fibrosis (CF) Therapeutics Market

19.1. Italy Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cystic Fibrosis (CF) Therapeutics Market

20.1. Spain Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cystic Fibrosis (CF) Therapeutics Market

21.1. Eastern Europe Cystic Fibrosis (CF) Therapeutics Market Overview

21.2. Eastern Europe Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cystic Fibrosis (CF) Therapeutics Market

22.1. Russia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cystic Fibrosis (CF) Therapeutics Market

23.1. North America Cystic Fibrosis (CF) Therapeutics Market Overview

23.2. North America Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cystic Fibrosis (CF) Therapeutics Market

24.1. USA Cystic Fibrosis (CF) Therapeutics Market Overview

24.2. USA Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cystic Fibrosis (CF) Therapeutics Market

25.1. Canada Cystic Fibrosis (CF) Therapeutics Market Overview

25.2. Canada Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cystic Fibrosis (CF) Therapeutics Market

26.1. South America Cystic Fibrosis (CF) Therapeutics Market Overview

26.2. South America Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cystic Fibrosis (CF) Therapeutics Market

27.1. Brazil Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cystic Fibrosis (CF) Therapeutics Market

28.1. Middle East Cystic Fibrosis (CF) Therapeutics Market Overview

28.2. Middle East Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cystic Fibrosis (CF) Therapeutics Market

29.1. Africa Cystic Fibrosis (CF) Therapeutics Market Overview

29.2. Africa Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cystic Fibrosis (CF) Therapeutics Market Competitive Landscape And Company Profiles

30.1. Cystic Fibrosis (CF) Therapeutics Market Competitive Landscape

30.2. Cystic Fibrosis (CF) Therapeutics Market Company Profiles

30.2.1. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Vertex Pharmaceuticals Incorporated Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Chiesi Farmaceutici SpA Overview, Products and Services, Strategy and Financial Analysis

30.2.5. PTC Therapeutics LIMITED Overview, Products and Services, Strategy and Financial Analysis

31. Cystic Fibrosis (CF) Therapeutics Market Other Major And Innovative Companies

31.1. Genentech Inc.

31.2. Alaxia

31.3. AstraZeneca

31.4. Beyond Air Inc.

31.5. Pfizer Inc.

31.6. Alcresta Therapeutics Inc.

31.7. Laurent Pharmaceuticals

31.8. Nestlé HealthScience

31.9. Pharmaxis

31.10. Bayer AG

31.11. AbbVie Inc.

31.12. Novartis AG

31.13. Arcturus Therapeutics Holdings Inc.

31.14. Arrowhead Pharmaceuticals Inc

31.15. ProQR Therapeutics N.V.

32. Global Cystic Fibrosis (CF) Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cystic Fibrosis (CF) Therapeutics Market

34. Recent Developments In The Cystic Fibrosis (CF) Therapeutics Market

35. Cystic Fibrosis (CF) Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Cystic Fibrosis (CF) Therapeutics Market In 2029 - Countries Offering Most New Opportunities

35.2 Cystic Fibrosis (CF) Therapeutics Market In 2029 - Segments Offering Most New Opportunities

35.3 Cystic Fibrosis (CF) Therapeutics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Cystic Fibrosis (CF) Therapeutics Market, Sub-Segmentation Of Pancreatic Enzyme Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Cystic Fibrosis (CF) Therapeutics Market, Sub-Segmentation Of Mucolytics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Cystic Fibrosis (CF) Therapeutics Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Cystic Fibrosis (CF) Therapeutics Market, Sub-Segmentation Of CFTR Modulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Cystic Fibrosis (CF) Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Cystic Fibrosis (CF) Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Table 79: F. Hoffmann-La Roche AG Financial Performance
  • Table 80: Vertex Pharmaceuticals Incorporated Financial Performance
  • Table 81: Chiesi Farmaceutici SpA Financial Performance
  • Table 82: PTC Therapeutics LIMITED Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Cystic Fibrosis (CF) Therapeutics Market, Sub-Segmentation Of Pancreatic Enzyme Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Cystic Fibrosis (CF) Therapeutics Market, Sub-Segmentation Of Mucolytics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Cystic Fibrosis (CF) Therapeutics Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Cystic Fibrosis (CF) Therapeutics Market, Sub-Segmentation Of CFTR Modulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Cystic Fibrosis (CF) Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Cystic Fibrosis (CF) Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Figure 79: F. Hoffmann-La Roche AG Financial Performance
  • Figure 80: Vertex Pharmaceuticals Incorporated Financial Performance
  • Figure 81: Chiesi Farmaceutici SpA Financial Performance
  • Figure 82: PTC Therapeutics LIMITED Financial Performance

In-Depth Skin Booster Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Skin Booster Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving STAY-C For Feed Market

Read More About 2025 Analysis: Opportunities and Risks in the Evolving STAY-C For Feed Market

Global Insights: Sustained Release Excipients Market Expected to Surpass $2.1 Billion by 2029

Read More About Global Insights: Sustained Release Excipients Market Expected to Surpass $2.1 Billion by 2029

2025 Thalassemia Drugs Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Thalassemia Drugs Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Blood Cancer Drugs Global Market Report 2025 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotin...

View Report

Cancer biologics Global Market Report 2025 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukem...

View Report

Rituximab Biosimilars Global Market Report 2025 – By Route Of Administration (Subcutaneous, Intravenous, Molecular Type), By Application (Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Other ...

View Report

Electrical Safety Personal Protective Equipment Global Market Report 2025 – By Product Type (Head Protection, Eye And Face Protection, Hearing Protection, Protective Footwear, Hand Protection, Arc Rated Clothing), By App...

View Report

In-Vehicle Payment Services Global Market Report 2025 – By Mode of Payment (QR Code or RFID, App-Based or e-Wallet, Credit or Debit Card-Based, Other Modes), By Form Factor (Embedded System, Tethered System, Integrated S...

View Report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2025 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/...

View Report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2025 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/...

View Report

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2025 – By Product (Instrument, Reagent), By Technology (NASBA, HAD), By Application (Blood Screening, Infectious Disease Diagnostics, Cancer),...

View Report

Frequently Asked Questions

Cystic fibrosis (CF) therapeutics refers to medications that thin and facilitate coughing up lung mucus. It is an inherited disorder that causes severe damage to the lungs, digestive system, and other organs in the body. For further insights on this market, request a sample here

The market major growth driver - Growing Patient Numbers Drive Momentum in Cystic Fibrosis Therapeutics Market. For further insights on this market, request a sample here

The cystic fibrosis (CF) therapeutics market size has grown strongly in recent years. It will grow from $7.63 billion in 2024 to $8.34 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to advancements in targeted therapies, growing understanding of CF genetics, patient advocacy and awareness, government support for research, orphan drug designations, incentives for rare disease research. The cystic fibrosis (CF) therapeutics market size is expected to see strong growth in the next few years. It will grow to " $10.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to rise in C patient population, regulatory approvals for novel therapies, focus on personalized medicine, increasing investment in biomarker research, expanded newborn screening programs, healthcare policy support. Major trends in the forecast period include expansion of CFTR modulators, gene editing technologies, early intervention strategies, improved diagnostic techniques, telehealth and remote monitoring, healthcare digitalization, chronic disease management. For further insights on this market, request a sample here

The cystic fibrosis (cf) therapeutics market covered in this report is segmented –
1) By Drug Class: Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators
2) By Route Of Administration: Oral, Inhaled
3) By Treatment Method: Medication, Devices Subsegments:
1) By Pancreatic Enzyme Supplements: Lipase, Amylase, Protease
2) By Mucolytics: Dornase Alfa (Pulmozyme), Hypertonic Saline
3) By Bronchodilators: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Anticholinergics
4) By CFTR Modulators: Ivacaftor, Lumacaftor Or Ivacaftor (Orkambi), Tezacaftor Or Ivacaftor (Symdeko), Elexacaftor Or Tezacaftor Or Ivacaftor For further insights on this market, request a sample here

North America was the largest region in the cystic fibrosis (CF) therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cystic fibrosis (CF) therapeutics market during the forecast period. The regions covered in the cystic fibrosis (CF) therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the cystic fibrosis (CF) therapeutics market include Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici SpA, PTC Therapeutics LIMITED, Genentech Inc., Alaxia, AstraZeneca, Beyond Air Inc., Pfizer Inc., Alcresta Therapeutics Inc., Laurent Pharmaceuticals, Nestlé HealthScience, Pharmaxis, Bayer AG, AbbVie Inc., Novartis AG, Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals Inc, ProQR Therapeutics N.V., Enterprise Therapeutics Ltd. , Corbus Pharmaceuticals Holdings Inc, Eloxx Pharmaceuticals , Translate Bio Inc, Zambon S.p.A . For further insights on this market, request a sample here.

Major trends in this market include Fibrosis Innovation Hub Network To Accelerate CF Treatment Development. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Cystic Fibrosis (CF) Therapeutics Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top